You are viewing: South Korea Cold Plasma Market analysis
Part of: Cold Plasma Market (Global)

The South Korea Cold Plasma Market was valued at $4.48 Million in 2024 and projected to reach to $6.56 Million by 2029, representing a compound annual growth rate of 7.9%. South Korea's cold plasma market is poised for sustained expansion as the nation's healthcare sector increasingly embraces cutting-edge plasma technologies for wound healing, sterilization, and dermatological applications.

South Korea Cold Plasma Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Cold Plasma Market Trends and Insights

  • Valued at $4.48 million in 2024, South Korea's market is projected to expand to $6.56 million by 2029, reflecting a compound annual growth rate of 7.9%.
  • This growth trajectory underscores South Korea's increasing adoption of advanced plasma technologies in clinical and therapeutic applications. The cold plasma market in South Korea is driven by rising healthcare investments and technological innovation in the country's medical device sector.
  • South Korea's strong manufacturing capabilities and regulatory framework support the development and commercialization of cold plasma solutions.
  • Between 2024 and 2029, South Korea is expected to see accelerated market penetration as healthcare providers and research institutions expand their utilization of cold plasma for wound healing, sterilization, and dermatological treatments. South Korea's position as a regional healthcare innovator positions the country favorably for cold plasma market expansion.
  • The nation's emphasis on precision medicine and advanced therapeutic technologies creates a conducive environment for cold plasma adoption, with South Korea likely to emerge as a key market within the broader Asia Pacific region..

Key Market Statistics

  • CAGR (2024-2029) 7.9% CAGR
  • Market Size, 2024 ~USD 4.48 Million
  • Forecast, 2029 ~USD 6.56 Million
  • Country South Korea

South Korea Cold Plasma Market Overview

Market Valuation :

South Korea's cold plasma market reached $4.48 million in 2024, demonstrating significant investment in advanced healthcare technologies and therapeutic innovations within the region.

Growth Trajectory :

With a CAGR of 7.9% through 2029, South Korea's market is expanding faster than many developed economies, driven by healthcare modernization and increased clinical adoption of plasma-based treatments.

Regional Position :

As a key player in Asia Pacific healthcare, South Korea leverages its advanced medical infrastructure and R&D capabilities to accelerate cold plasma technology integration across clinical settings.

Forecast Growth :

The market is projected to reach $6.56 million by 2029, representing a 46% increase over five years and reflecting growing confidence in cold plasma's therapeutic potential among South Korean healthcare providers.

South Korea Cold Plasma Market Dynamics

  • The country's strong emphasis on medical innovation, coupled with government support for advanced healthcare solutions, creates a favorable environment for market growth.
  • South Korean hospitals and clinics are progressively integrating cold plasma systems into their therapeutic protocols, driven by clinical efficacy data and patient demand for non-invasive treatment options. Looking ahead to 2029, South Korea's cold plasma market will benefit from continued technological refinement, expanded clinical applications, and growing awareness among healthcare professionals.
  • The nation's robust medical device manufacturing sector and export-oriented economy position it as a regional hub for cold plasma innovation.
  • Increased collaboration between research institutions and healthcare providers will further accelerate market penetration, particularly in specialized medical centers and emerging therapeutic areas..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • South Korea's cold plasma market is valued at $4.48 million in 2024 and is forecast to reach $6.56 million by 2029.
    • South Korea demonstrates a 7.9% CAGR, reflecting moderate but consistent market expansion driven by healthcare innovation.
    • South Korea's advanced medical device manufacturing and regulatory infrastructure support cold plasma technology commercialization.
    • South Korea is positioned as a key regional player in cold plasma adoption within Asia Pacific healthcare.

    Cold Plasma Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment MEDICAL INDUSTRY (Industry)
    Forecast Period 2024-2029
    Growth Rate CAGR of 11% from 2024 to 2029
    Largest Segment ATMOSPHERIC COLD PLASMA (Regime)
    Market Size Base Year (Billions) ~USD 2.14 (2024)
    Revenue Forecast (Billions) ~USD 3.6 (2029)
    Segments Covered Industry, Application, Regime

    South Korea Cold Plasma Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Industry

    • Cosmetic Industry
    • Electronics & Semiconductors Industry
    • Food & Agriculture Industry
    • Medical Industry
    • Other Industries
    • Polymer & Plastic Industry
    • Textile Industry

    By Application

    • Aesthetic Procedures
    • Coating & Thin-Film Deposition
    • Other Applications
    • Printing
    • Surface Cleaning & Decontamination
    • Surface Etching
    • Surface Treatment & Activation
    • Surgical
    • Wound Healing

    By Regime

    • Atmospheric Cold Plasma
    • Low-Pressure Cold Plasma

    Target Audience

    • Medical Device Manufacturers : South Korean and international device makers need precise market data to assess expansion opportunities, benchmark competitive positioning, and develop localized cold plasma solutions for the Korean healthcare market.
    • Healthcare Investors : Investment firms and venture capitalists require detailed South Korea market analysis to evaluate funding opportunities in cold plasma startups, medical technology companies, and healthcare innovation ventures.
    • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to justify capital investments in cold plasma equipment, understand adoption trends among peer institutions, and plan technology integration strategies.
    • Market Research & Consulting Firms : Research organizations require country-specific data to support client advisory services, competitive analysis, and strategic recommendations for companies operating in South Korea's healthcare sector.
    • Government & Policy Makers : South Korean health ministry officials and policy advisors need market intelligence to inform healthcare technology regulations, innovation incentives, and strategic healthcare modernization initiatives.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for South Korea's cold plasma market ($4.48M in 2024) with detailed forecasts through 2029, enabling accurate budget allocation and investment planning for regional operations.
    • Competitive Intelligence : Understand South Korea's unique market dynamics, local player strategies, and competitive positioning within Asia Pacific, providing actionable insights for market entry or expansion decisions.
    • Growth Opportunity Assessment : Leverage the 7.9% CAGR data to identify high-potential segments within South Korea's healthcare sector and prioritize resource allocation toward the most promising therapeutic applications and customer segments.
    • Regional Healthcare Trends : Gain insights into South Korea's adoption patterns of advanced plasma technologies, clinical integration rates, and healthcare provider preferences that inform product development and go-to-market strategies.
    • Strategic Planning Support : Use country-specific market intelligence to develop targeted business strategies, partnership opportunities, and investment decisions tailored to South Korea's healthcare landscape and regulatory environment.

    Frequently asked questions

    What is the current size of South Korea's cold plasma market?

    South Korea's cold plasma market was valued at $4.48 million in 2024 and is expected to grow to $6.56 million by 2029.

    What is the projected growth rate for cold plasma in South Korea?

    South Korea's cold plasma market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2029.

    What factors are driving cold plasma market growth in South Korea?

    South Korea's cold plasma market growth is driven by increased healthcare investments, technological innovation in medical devices, and expanding clinical applications in wound healing and dermatology.

    How does South Korea's cold plasma market compare to the global market?

    South Korea's 7.9% CAGR is lower than the global 11% CAGR, indicating a more measured adoption pace while still maintaining steady regional growth.

    What applications are driving cold plasma adoption in South Korea?

    South Korea's cold plasma adoption is primarily driven by applications in wound healing, sterilization, and dermatological treatments within healthcare facilities and research institutions.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Plasma Protein Therapeutic Association (PPTA), International Diabetes Federation (IDF),European Textile Services Association (ETSA), National Council of Textile Organizations (NCTO), Semiconductor Industry Association (SIA), International Journal of Plastic and Polymer Technology (IJPPT), International Journal of Engineering Research & Technology (IJERT and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global cold plasma market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the cold plasma market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global cold plasma market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global cold plasma market was split into various segments and sub-segments based on:

    • List of major players operating in the cold plasma   products market at the regional and/or country level
    • Product mapping of various cold plasma   manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from cold plasma (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Data Triangulation

    After arriving at the overall size of the global cold plasma market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and excited & ground-state molecules. It is an innovative and convenient alternative to traditional and conventional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.

    Stakeholders

    • Cold plasma manufacturers and distributors
    • Government and research organizations
    • Cold plasma application industries
    • Medical device manufacturing companies
    • Healthcare organizations
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Corporate entities

    Report Objectives

    • To define, measure, and describe the global cold plasma  market by industry, application, regime, and region
    • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
    • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To strategically analyze the market structure, profile the key players in the global cold plasma  market, and comprehensively analyze their core competencies
    • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the cold plasma  market

    Get the Full Cold Plasma Market Report

    Full forecast, segment splits, and company analysis for all Cold Plasma Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status